Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medistim Director's Dealing 2015

Nov 3, 2015

3662_dirs_2015-11-03_58d0fecd-0032-46cd-9ca9-df585f020809.html

Director's Dealing

Open in viewer

Opens in your device viewer

CEO in Medistim ASA purchases shares for NOK 900.000

CEO in Medistim ASA purchases shares for NOK 900.000

Board of directors in Medistim ASA has decided to sell

25,000 Medistim shares to NOK 36 per share to CEO Kari

Krogstad. Kari Krogstad is paying NOK 900.000 for

additional shares in Medistim. The share price at

inception was NOK 44.8 and the shares will be

transferred at this value. Medistim ASA had 221,000

own shares and after the sale to Kari Krogstad this is

reduced to 196,000 own shares. Kari Krogstad has after

the last trade 80,000 shares in Medistim ASA.